About Solute carrier family 38 member 6
Solute carrier family 38 member 6 (SLC38A6) is a protein
from Homo sapiens identified by UniProt accession
Q8IZM9, 456 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Solute carrier family 38 member 6 |
| UniProt accession | Q8IZM9 |
| Gene | SLC38A6 |
| Organism | Homo sapiens |
| Length | 456 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- cortical surface area measurement · score 0.16
- lip morphology measurement · score 0.14
- optic cup area measurement · score 0.04
- cytokine measurement · score 0.04
- response to vaccine · score 0.04
- vital capacity · score 0.03
- Sepsis · score 0.03
- type 2 diabetes mellitus · score 0.03
- Abnormal urine sodium concentration · score 0.02
- hepatocellular carcinoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IZM9-F1 | alphafold | PREDICTED | 84.08 | — |
Amino-acid sequence (456 residues)
MEASWGSFNA ERGWYVSVQQ PEEAEAEELS PLLSNELHRQ RSPGVSFGLS VFNLMNAIMG SGILGLAYVL ANTGVFGFSF LLLTVALLAS YSVHLLLSMC IQTAVTSYED LGLFAFGLPG KLVVAGTIII QNIGAMSSYL LIIKTELPAA IAEFLTGDYS RYWYLDGQTL LIIICVGIVF PLALLPKIGF LGYTSSLSFF FMMFFALVVI IKKWSIPCPL TLNYVEKGFQ ISNVTDDCKP KLFHFSKESA YALPTMAFSF LCHTSILPIY CELQSPSKKR MQNVTNTAIA LSFLIYFISA LFGYLTFYDK VESELLKGYS KYLSHDVVVM TVKLCILFAV LLTVPLIHFP ARKAVTMMFF SNFPFSWIRH FLITLALNII IVLLAIYVPD IRNVFGVVGA STSTCLIFIF PGLFYLKLSR EDFLSWKKLG AFVLLIFGIL VGNFSLALII FDWINK
Explore Solute carrier family 38 member 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets